2022
DOI: 10.1016/j.str.2022.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…The structures of several key proteins of Mtb have been elucidated, e.g., membrane transporter MmpL3 [82,83], RNase J [84], fatty acyl-AMP ligase FadD32 [85], acetyltransferase Eis [86], EF-Tu/EF-Ts [49], EF-G [68], and nucleoside triphosphate pyrophosphohydrolase MazG [87]. Inhibitors of these proteins are considered promising for the treatment of tuberculosis, among which 11 potential anti-tuberculosis drugs have been obtained by Li et al, based on the rational drug of acetyltransferase Eis [86].…”
Section: Computer-aided Structure-based Anti-tuberculosis Drug Designmentioning
confidence: 99%
See 1 more Smart Citation
“…The structures of several key proteins of Mtb have been elucidated, e.g., membrane transporter MmpL3 [82,83], RNase J [84], fatty acyl-AMP ligase FadD32 [85], acetyltransferase Eis [86], EF-Tu/EF-Ts [49], EF-G [68], and nucleoside triphosphate pyrophosphohydrolase MazG [87]. Inhibitors of these proteins are considered promising for the treatment of tuberculosis, among which 11 potential anti-tuberculosis drugs have been obtained by Li et al, based on the rational drug of acetyltransferase Eis [86].…”
Section: Computer-aided Structure-based Anti-tuberculosis Drug Designmentioning
confidence: 99%
“…Inhibitors of these proteins are considered promising for the treatment of tuberculosis, among which 11 potential anti-tuberculosis drugs have been obtained by Li et al, based on the rational drug of acetyltransferase Eis [86]. Hu et al designed anti-mycobacterial drugs that target MmpL3 using a structure-based drug design [83]. Translation elongation factors have been considered key drug targets.…”
Section: Computer-aided Structure-based Anti-tuberculosis Drug Designmentioning
confidence: 99%
“…Three-dimensional structures of the apo forms of MmpL3 solved either by X-ray crystallography or cryo-EM as well as in complex with TMM or MmpL3 inhibitors shed light on the mechanism of TMM transport and its inhibition. To date sixteen three-dimensional structures of MmpL3 from Mycobacterium smegmatis (hereafter MmpL3 Msm ) were solved of which nine were determined by X-ray crystallography and seven by cryo-EM, all of the latter were reconstituted in lipid nanodiscs ( Hu et al, 2022 ; Su et al, 2019 , 2021 ; Yang et al, 2020 ; Zhang et al, 2019 ). One additional MmpL3 structure from Mtb was solved by cryo-EM ( Adams et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%